Johnson & Johnson Announces Donation of up to 500,000 Regimens of Janssen's Investigational Ebola Vaccine to Support Outbreak Response in Democratic Republic of the Congo (DRC)
J&J's Heaton becomes face of COVID-19 booster debate in first months as Janssen vaccine chief | Fierce Biotech
Medical Countermeasures | USA Public Health Security
AdventHealth begins recruiting participants for Phase 3 COVID-19 Investigational vaccine clinical trial | AdventHealth Research Institute
J&J's Janssen Speeds Up Planned Launch of COVID-19 Vaccine Trial
Johnson & Johnson (Janssen Pharmaceutical Cos.) - Single-Shot COVID-19 Vaccine (formerly JNJ-78436735, Ad26.COV2.S)
Janssen Investigational COVID-19 Vaccine Program
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
COVID-19 Vaccine Could Cost As Little As $10 A Dose, Says Janssen :: Scrip
J&J statement on Janssen vaccine approval | Healthcare Purchasing News
Johnson & Johnson seeks EU approval for its COVID-19 vaccine
Johnson & Johnson Unveils New Vaccines Launch Facility in Holland
Johnson & Johnson starts global Phase 3 trial for Janssen COVID-19 vaccine
COVID-19 Vaccine Janssen, INN-Ad26.COV2-S, recombinant
J&J partners HHS to speed-up coronavirus vaccine development
J&J working with Beth Israel to accelerate COVID-19 vaccine developmen
Janssen's AdVac® Technology - YouTube
